Verastem Oncology
VSTM
#8224
Rank
โ‚น13.41 B
Marketcap
โ‚น333.28
Share price
9.72%
Change (1 day)
-40.03%
Change (1 year)

Earnings for Verastem Oncology (VSTM)

Earnings in 2024 (TTM): -โ‚น7.46 Billion

According to Verastem Oncology 's latest financial reports the company's current earnings are โ‚น10 Million. In 2023 the company made an earning of -โ‚น7.38 Billion a decrease over its 2022 earnings that were of -โ‚น6.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verastem Oncology from 2011 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น7.46 Billion1.12%
2023 -โ‚น7.38 Billion18.36%
2022 -โ‚น6.23 Billion3.67%
2021 -โ‚น6.01 Billion5.43%
2020 -โ‚น5.7 Billion-54.74%
2019 -โ‚น12.59 Billion105.99%
2018 -โ‚น6.12 Billion6.83%
2017 -โ‚น5.73 Billion86.06%
2016 -โ‚น3.08 Billion-37.03%
2015 -โ‚น4.89 Billion8.43%
2014 -โ‚น4.51 Billion29.52%
2013 -โ‚น3.48 Billion28.6%
2012 -โ‚น2.71 Billion133.9%
2011 -โ‚น1.16 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น3.94 Billion-47.92%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น102.27 Billion 1,254.33%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น69.38 B-1,018.86%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น351.91 B-4,760.66%๐Ÿ‡ฌ๐Ÿ‡ง UK